Back
Rapt Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
70
RAPT
Rapt Therapeutics, Inc.
Last Price:
$57.54
Seasonality Move:
-37.09%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing slight buying pressure.
Rapt Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.61 | Buy |
| 20-day SMA: | 34.89 | Buy |
| 50-day SMA: | 32.89 | Buy |
| 200-day SMA: | 18.49 | Buy |
| 8-day EMA: | 38.97 | Buy |
| 20-day EMA: | 35.75 | Buy |
| 50-day EMA: | 32.92 | Buy |
| 200-day EMA: | 24.36 | Buy |
Rapt Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.15 | Buy |
| Relative Strength Index (14 RSI): | 80.09 | Buy |
| Chaikin Money Flow: | 14899991 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.8 - 39.72) | Buy |
| Bollinger Bands (100): | (20.72 - 35.74) | Buy |
Rapt Therapeutics, Inc. Technical Analysis
| Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rapt Therapeutics, Inc. Stock
Is Rapt Therapeutics, Inc. Stock a Buy?
-
Rapt Therapeutics, Inc. share price is 57.57 while RAPT 8-day simple moving average is 36.61, which is a Buy signal.
-
The stock price of RAPT is 57.57 while Rapt Therapeutics, Inc. 20-day SMA is 34.89, which makes it a Buy.
-
Rapt Therapeutics, Inc. 50-day simple moving average is 32.89 while RAPT share price is 57.57, making it a Buy technically.
-
RAPT stock price is 57.57 and Rapt Therapeutics, Inc. 200-day simple moving average is 18.49, creating a Buy signal.
RAPT Technical Analysis vs Fundamental Analysis
Buy
70
Rapt Therapeutics, Inc. (RAPT)
is a Buy
Is Rapt Therapeutics, Inc. a Buy or a Sell?
-
Rapt Therapeutics, Inc. stock is rated a BuyThe current Rapt Therapeutics, Inc. [RAPT] share price is $57.57. The Score for RAPT is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
Rapt Therapeutics, Inc. Stock Info
Market Cap:
952.1M
Price in USD:
57.57
Share Volume:
31.9M
Rapt Therapeutics, Inc. 52-Week Range
52-Week High:
57.61
52-Week Low:
5.67
Buy
70
Rapt Therapeutics, Inc. (RAPT)
is a Buy
Rapt Therapeutics, Inc. Share Price Forecast
-
What is the Rapt Therapeutics, Inc. stock price today?The Rapt Therapeutics, Inc. stock price is 57.57 USD today.
-
Will RAPT stock go up or go down?Rapt Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Rapt Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rapt Therapeutics, Inc. is not overvalued.
Is Rapt Therapeutics, Inc. Stock a Buy?
-
Rapt Therapeutics, Inc. share price is 57.57 while RAPT 8-day exponential moving average is 38.97, which is a Buy signal.
-
The stock price of RAPT is 57.57 while Rapt Therapeutics, Inc. 20-day EMA is 35.75, which makes it a Buy.
-
Rapt Therapeutics, Inc. 50-day exponential moving average is 32.92 while RAPT share price is 57.57, making it a Buy technically.
-
RAPT stock price is 57.57 and Rapt Therapeutics, Inc. 200-day simple moving average is 24.36, creating a Buy signal.
Fundamental Analysis of Rapt Therapeutics, Inc.
Is Rapt Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $1.24 per share.
Technical Analysis of Rapt Therapeutics, Inc.
Should I short Rapt Therapeutics, Inc. stock?
-
RAPT Moving Average Covergence Divergence (MACD) indicator is 2.15, suggesting Rapt Therapeutics, Inc. is a Buy
-
Rapt Therapeutics, Inc. Relative Strength Index (RSI) is 80.09, which suggest Rapt Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Rapt Therapeutics, Inc. is (29.8 - 39.72), which suggest Rapt Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Rapt Therapeutics, Inc. is (20.72 - 35.74), which suggest Rapt Therapeutics, Inc. is a Buy
* Rapt Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.